MD Pharma Consulting GroupMay 19, 20196 minRecent Advances in Treatment of Stage IV Metastatic Breast CancerBreast cancer is the most common cancer type in women worldwide. It is estimated that 70% of patients with breast cancer are estrogen...
MD Pharma Consulting GroupApr 19, 20194 minRecent Advances in Treatment of Stage IV Metastatic Non-Small Cell Lung CancerNon-small cell lung cancer (NSCLC) is the most common type of lung cancer. Approximately 40% of NSCLC patients are diagnosed with stage...
MD Pharma Consulting GroupMar 19, 20196 minChoosing the Right Immunoassays for Your Radiobiology ExperimentsRadiation therapy is one of the most common treatments for cancer. In order to improve the treatment efficacy of radiation therapies,...
